Clinical Trials Logo

Crigler-Najjar Syndrome clinical trials

View clinical trials related to Crigler-Najjar Syndrome.

Filter by:
  • Terminated  
  • Page 1

NCT ID: NCT03343756 Terminated - Clinical trials for Acute on Chronic Liver Failure

HepaStem Long-Term Safety Registry

PROLONGSTEM
Start date: April 4, 2018
Phase:
Study type: Observational

All patients having received at least one infusion of the Investigational Medicinal Product (IMP) HepaStem HHALPC during a previous interventional clinical study conducted by Promethera Biosciences

NCT ID: NCT03223194 Terminated - Clinical trials for Crigler-Najjar Syndrome

Gene Transfer Clinical Study in Crigler-Najjar Syndrome

VALENS
Start date: September 8, 2017
Phase: Phase 1
Study type: Interventional

This is a Phase 1/2, multinational, open-label, ascending-dose, delayed-treatment concurrent control clinical study to evaluate the safety and preliminary efficacy of AT342 in subjects with Crigler-Najjar aged ≥1 year. Subjects will receive a single dose of AT342 and will be followed for safety and efficacy for 5 years.